These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11278931)

  • 1. A novel osteoblast-derived C-type lectin that inhibits osteoclast formation.
    Zhou H; Kartsogiannis V; Hu YS; Elliott J; Quinn JM; McKinstry WJ; Gillespie MT; Ng KW
    J Biol Chem; 2001 May; 276(18):14916-23. PubMed ID: 11278931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of a human homolog of osteoclast inhibitory lectin that inhibits the formation and function of osteoclasts.
    Hu YS; Zhou H; Myers D; Quinn JM; Atkins GJ; Ly C; Gange C; Kartsogiannis V; Elliott J; Kostakis P; Zannettino AC; Cromer B; McKinstry WJ; Findlay DM; Gillespie MT; Ng KW
    J Bone Miner Res; 2004 Jan; 19(1):89-99. PubMed ID: 14753741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclast inhibitory lectin, a family of new osteoclast inhibitors.
    Zhou H; Kartsogiannis V; Quinn JM; Ly C; Gange C; Elliott J; Ng KW; Gillespie MT
    J Biol Chem; 2002 Dec; 277(50):48808-15. PubMed ID: 12374791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
    Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
    J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
    Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
    Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation.
    Wang X; Wu J; Shidoji Y; Muto Y; Ohishi N; Yagi K; Ikegami S; Shinki T; Udagawa N; Suda T; Ishimi Y
    J Bone Miner Res; 2002 Jan; 17(1):91-100. PubMed ID: 11771673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.
    Kartsogiannis V; Zhou H; Horwood NJ; Thomas RJ; Hards DK; Quinn JM; Niforas P; Ng KW; Martin TJ; Gillespie MT
    Bone; 1999 Nov; 25(5):525-34. PubMed ID: 10574572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone-related protein regulates osteoclast inhibitory lectin expression via multiple signaling pathways in osteoblast-like cells.
    Zheng F; Liang H; Liu R; Quan JX; Li XX; Dai CL; Guo G; Zhang JY; Wang BL
    Endocrine; 2009 Feb; 35(1):47-56. PubMed ID: 18987998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of sugar binding by osteoclast inhibitory lectin.
    Gange CT; Quinn JM; Zhou H; Kartsogiannis V; Gillespie MT; Ng KW
    J Biol Chem; 2004 Jul; 279(28):29043-9. PubMed ID: 15123656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis.
    Tsurukai T; Udagawa N; Matsuzaki K; Takahashi N; Suda T
    J Bone Miner Metab; 2000; 18(4):177-84. PubMed ID: 10874596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
    J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.
    Romas E; Udagawa N; Zhou H; Tamura T; Saito M; Taga T; Hilton DJ; Suda T; Ng KW; Martin TJ
    J Exp Med; 1996 Jun; 183(6):2581-91. PubMed ID: 8676079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoclast inhibitory lectin, an immune cell product that is required for normal bone physiology in vivo.
    Kartsogiannis V; Sims NA; Quinn JM; Ly C; Cipetic M; Poulton IJ; Walker EC; Saleh H; McGregor NE; Wallace ME; Smyth MJ; Martin TJ; Zhou H; Ng KW; Gillespie MT
    J Biol Chem; 2008 Nov; 283(45):30850-60. PubMed ID: 18782774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meltrin-alpha, a fusion protein involved in multinucleated giant cell and osteoclast formation.
    Abe E; Mocharla H; Yamate T; Taguchi Y; Manolagas SC
    Calcif Tissue Int; 1999 Jun; 64(6):508-15. PubMed ID: 10341023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
    Nagata N; Kitaura H; Yoshida N; Nakayama K
    Bone; 2003 Oct; 33(4):721-32. PubMed ID: 14555278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.